interface language
English
Français
content language
All
English
Français
countries
World
United States
United Kingdom
Canada
Australia
South Africa
Israel
India
France
Belgium
Switzerland
Pharmaceutical Industry
Develops, produces, and markets drugs or pharmaceuticals licensed for use as medications
More
related topics
Medication
Vaccine
Biotechnology
Food and Drug Administration
Pfizer
Drug
AstraZeneca
Generic Drug
Sanofi
Drug Development
GlaxoSmithKline
Johnson & Johnson
Treatment
BioNTech (Germany)
Merck & Co.
Prescription Drug
Novartis
Gilead Sciences
Health Care
trends
October
November
December
2021
February
March
0
500
5,665 articles (0.03 seconds)
11 things you need to know about the COVID stimulus the Senate is taking up
1 hours ago
The Senate made a few last-minute changes to the COVID stimulus, including narrowing down who gets a check. Senators are set to vote on it this weekend.
Science & Technology
www.businessinsider.com
EU, Italy stop AstraZeneca vaccine exports to Australia
5 hours ago
A shipment of a quarter million AstraZeneca vaccines destined for Australia has been blocked from leaving the European Union in the first use of an export...
news.yahoo.com
Tergus Pharma Hires Heather N. Sugrue as VP of Business Development
8 hours ago
Key Hire Primes Tergus for Growth in 2021
www.prweb.com
'Held to ransom': Pfizer demands governments gamble with state assets to secure vaccine deal
14 hours ago
The Bureau has learned that the pharmaceutical giant also insists on indemnity against its own negligence in hardball negotiations with Latin American countries
Science & Technology
www.thebureauinvestigates.com
Catholics urged by U.S. church leadership to avoid Johnson & Johnson COVID-19 vaccine
20 hours ago
Catholic leaders are urging the faithful to avoid the Johnson & Johnson coronavirus vaccine if they can because it is produced using cell lines derived from abortions decades ago.
Politics
www.washingtontimes.com
Johnson & Johnson CEO Alex Gorsky on business after COVID-19
1 days ago
"I hope we don't go back to doing business as usual," Johnson & Johnson CEO Alex Gorsky said in an interview with the Washington Post.
Science & Technology
www.businessinsider.com
How to Administer RNA – And How to Do It Again
1 days ago
As the world knows, the mRNA vaccines for the coronavirus are proving to be very effective. That's welcome news for the obvious pandemic reasons, but it's also welcome validation for a technique that's been in the works for many years now. I'll take a moment to re-emphasize how fortunate we are that
Science & Technology
blogs.sciencemag.org
Why Johnson & Johnson's COVID-19 vaccine will help in the fight to end the pandemic
1 days ago
On Feb. 27, the Johnson & Johnson COVID-19 vaccine was granted emergency use authorization by the FDA. Yahoo News Medical Contributor Dr. Kavita Patel...
Health
news.yahoo.com
JW Asset Management shares the 6 cannabis stocks its betting on now
1 days ago
Jason Wild of top-performing hedge fund JW Asset Management shared with Insider the 6 cannabis stocks he's betting on this year.
Science & Technology
www.businessinsider.com
Life Molecular Imaging announces an ongoing collaboration with UCB for PI-2620, a novel tau imaging agent, for…
1 days ago
Data from PI-2620 suggest that it could be an important biomarker of tau pathology in PSP patients
www.prweb.com
Merck will help make Johnson & Johnson's vaccine in a deal brokered by Biden
2 days ago
This it's an unprecedented collaboration between formerly competing pharmaceutical companies.
qz.com
Vaccine Passports, Covid's Next Political Flash Point
2 days ago
The next major flash point over coronavirus response has already provoked cries of tyranny and discrimination in Britain, protests in Denmark, digital disinformation in the United States and geopolitical skirmishing within the European Union. The subject of debate: vaccine passports — government-issued cards or smartphone badges stating that the bearer has been inoculated against the coronavirus. The idea is to…
Politics
www.msn.com
Biden: US will be able to vaccinate all adults by end of May
2 days ago
The announcement comes as the White House looks to speed the production of the single-dose J&J vaccine and accelerate the nation's plans to reach "herd immunity" in the U.S. and begin restoring normalcy after the pandemic.
chicago.suntimes.com
Abbott says researchers in the Democratic Republic of Congo have made findings that could lead to HIV vaccine
2 days ago
Medical device, diagnostics and generic drug maker Abbott undefined said Tuesday a team of scientists has found an unusually high number of people in the...
Health
www.marketwatch.com
U.S. and European COVID-19 Vaccines Aren't Enough—Time to Tap Into Africa, Asia, and Latin America's Production…
3 days ago
U.S. and European COVID-19 shots aren't enough. It is time to tap into Africa, Asia, and Latin America's enormous production capacity.
foreignpolicy.com
Medipure Holdings Inc. Announces a Milestone for its Proprietary Anxiety and Mood Disorder Medication
3 days ago
United States Patent and Trademark Office Issues Notice of Allowance
www.prweb.com
Harnessing the power of proteins in our cells to combat disease
4 days ago
Over many decades now, traditional drug discovery methods have steadily improved at keeping diseases at bay and cancer in remission. And for the most part, it's worked well. But it hasn't worked perfectly.
Health
www.sciencedaily.com
Why AstraZeneca and J&J's Vaccines, In Use Elsewhere, Are Still on Hold in America
5 days ago
Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever — which are still painfully slow, critics say.
Health
khn.org
Top Buys Today As Tech Leads And Dow Lags In Reverse Rotation
1 weeks ago
After the rise of 10-year yields terrified investors, the indices "reverse rotated" back into the Nasdaq and out of the Dow. Make the most of this market with today's top buys, from Q.ai's Artificial Intelligence.
Business
www.forbes.com
Mitotech and Essex Bio-Technology announce positive results of VISTA-2 Phase 3 clinical study in Dry Eye Disease
1 weeks ago
Both VISTA-2 and VISTA-1 demonstrated significant impact of SkQ1 on clearing of Central Corneal Fluorescein Staining (CCFS) and improvement of Best Corrected Visual Acuity (BCVA) at day 28 (p<0.05 for both endpoints in VISTA-1 and VISTA-2), providing clear guidance for primary endpoint designation in the next pivotal study for the purpose of NDA submission.
www.prweb.com
Previous
Next